Coronary/Structural Heart

Cordis and Medinol Announce FDA Approval of the Innovative EluNIR Drug-Eluting Stent System

DUBLIN, Ohio, Nov. 30, 2017 /PRNewswire/ — Cordis, a Cardinal Health company, and Medinol today announced United States Food and Drug Administration (FDA) approval of the EluNIR™ drug-eluting stent (DES) for the treatment of patients with narrowing or blockages to their coronary arteries. The EluNIR™ stent system is designed with a novel metallic […]

China successfully completes the country’s first human implantation of a retrievable transcatheter aortic valve

HANGZHOU, China, Nov. 28, 2017 /PRNewswire/ — The first human implantation of the VenusA Plus retrievable valve system was completed successfully at the Second Affiliated Hospital of Zhejiang University School of Medicine (SAHZU) on November 23, 2017. Prof. Wang Jian‘an, president of SAHZU, announced that China has completed its first successful human implantation of a retrievable […]

Boston Scientific Announces Update on LOTUS Edge™ Aortic Valve System

MARLBOROUGH, Mass., Nov. 28, 2017 /PRNewswire/ — Boston Scientific (NYSE: BSX) announces a delay to previously communicated timelines for commercialization of the LOTUS Edge™ Aortic Valve System* in Europe and the U.S. After initiating a voluntary recall for the LOTUS and LOTUS Edge Aortic Valve Systems earlier this year, Boston Scientific implemented manufacturing process and design […]

European doctors learn to access the heart from any approach with Baylis devices and expanded training program

TORONTO, Nov. 21, 2017 /PRNewswire/ – Baylis Medical Company Inc. has launched a hands-on workshop in Europe that will train cardiologists on innovative tools that enable access to the heart from any approach. This includes a growing number of procedures that require physicians to use major veins that feed into the heart from above […]

HeartStitch® “Sutures The Future” at the TCT in Denver, Colorado

FOUNTAIN VALLEY, Calif., Nov. 20, 2017 /PRNewswire/ — TCT 2017 in Denver, Colorado, provided a forum for Interventional Cardiologists from around the world to discover the HeartStitch® Suture-Based Solutions to Structural Heart Procedures. These key procedures of interest include septal repair, mitral and tricuspid valve repair and new access and closure techniques, all areas HeartStitch® has […]

Xeltis Closes $52M for Replacement Heart Valve Programs

EINDHOVEN, The Netherlands and ZURICH, November 15, 2017 /PRNewswire/ — Xeltis, a clinical-stage medical device company pioneering a restorative approach in heart valve therapy, today announced the completion of an oversubscribed EUR45 million ($52 million) Series C financing. The funding round was led by a global strategic investor with participation […]

Corvia Medical Announces Enrollment of First Patients in Pivotal Trial of the IASD System II for the Treatment of Heart Failure

ANAHEIM, Calif., Nov. 14, 2017 /PRNewswire/ — Corvia Medical, Inc., a privately-held medical device company that developed a first-in-class transcatheter structural heart device to treat heart failure, today announced that it has enrolled the first patients in its global multicenter trial (REDUCE LAP-HF II) of the Interatrial Shunt Device (IASD) […]

Plaxgen Plaque Array Lipid-Modifying Drugs Study Published in Journal of Visualized Experiments

FREMONT, Calif., Nov. 13, 2017 /PRNewswire/ — Plaxgen Inc,developing flow cytometry-based blood diagnostics for plaque-associated diseases, such as atherosclerosis and Alzheimer’s, announced that new research exploring the effect of lipid-lowering drugs, including statins, on the morphology of cholesterol particles in human serum samples was published in the peer-reviewed journal, “Journal of […]